Demonstration of focal physiologic in-vivo somatostatin receptor expression in the caput epididymis of the testes on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE post-therapy whole body scintigraphy

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

We present the case of a 60-year-old man with metastatic neuroendocrine tumor of the ileum following ileal resection, being evaluated for 177Lu-based peptide receptor radionuclide therapy. 68Ga-DOTANOC PET/CT showed focal increased tracer uptake in the scrotal region without any morphologic changes on the corresponding CT images. Similar increased tracer uptake was seen on post-therapy whole-body imaging following 177Lu-DOTATATE therapy. An USG guided FNA revealed no malignant cells on cytopathologic examination. This case illustrates that focal testicular tracer uptake, may not always be pathological and can represent a normal physiologic variant, similar to the diffuse testicular somatostatin receptor expression as previously reported in literature.

Original languageEnglish
Pages (from-to)132-135
Number of pages4
JournalAsia Oceania Journal of Nuclear Medicine and Biology
Volume8
Issue number2
DOIs
StatePublished - 2020

Keywords

  • Lu-DOTATATE
  • Ga-DOTANOC- PET/CT
  • DOTATOC
  • Neuroendocrine tumor
  • Physiologic
  • Somatostatin receptor
  • Testicular uptake

Fingerprint

Dive into the research topics of 'Demonstration of focal physiologic in-vivo somatostatin receptor expression in the caput epididymis of the testes on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE post-therapy whole body scintigraphy'. Together they form a unique fingerprint.

Cite this